Apeiron Synthesis: Partnering Industry with Cutting-Edge Catalysis

By Your Health Magazine

Sponsored content

Catalysis plays a decisive role in helping the chemical industry meet expectations for efficiency, scalability, and sustainability. Within this context, olefin metathesis has emerged as one of the most versatile and industrially relevant transformations.

By reforging carbon–carbon double bonds with high atom economy, it enables shorter synthetic routes, access to new building blocks, and integration of renewable feedstocks.

Focused on Olefin Metathesis

Unlike companies that treat olefin metathesis as one option among many, Apeiron Synthesis concentrates exclusively on this chemical transformation. The company develops and manufactures advanced ruthenium-based catalysts, designed to perform under real process conditions.

By tailoring the design of carbene ligands, such as NHC and CAAC systems, Apeiron delivers catalysts that combine high turnover numbers with robustness in the presence of air, moisture, or impure feedstocks.

Industrial Applications

Metathesis enables practical solutions across several sectors:

Pharmaceuticals – clean access to complex intermediates and final API with low residual metal, supporting efficient development of drug candidates.
Renewable chemicals – ethenolysis of fatty acid esters into 9-DAME and 1-decene, providing essential building blocks for surfactants, lubricants, and other bio-based specialty chemicals.
Fine chemicals – scalable metathesis routes, including ring-closing metathesis, enabling the synthesis of pheromones, agrochemical intermediates, specialty molecules, macrocyclic musks, and other high-value aroma compounds.
Polymers and advanced materials – ROMP and ADMET catalysts enabling high-performance composites and tailored polymer architectures.

In each case, Apeiron’s catalysts translate laboratory reactivity into reproducible industrial outcomes.

Beyond Catalyst Supply

Apeiron is not only a manufacturer of catalysts but also a partner in process development. Through dedicated CDMO and CRO services, the company supports partners with catalyst screening, process optimization, and scale-up to kilogram and multi-kilogram quantities. This model ensures that industrial users receive not just a chemical product, but a reliable solution integrated into their production.

A Strategic Partner

The chemical industry continues to demand scalable, sustainable, and selective tools. Apeiron’s singular focus, proprietary IP, and application-optimized portfolio position
the company as a strategic partner for organizations adopting metathesis at scale.

With proven results across pharmaceuticals, renewables, fine chemicals, and polymers, Apeiron Synthesis demonstrates how focused innovation in catalysis can deliver tangible value to industry.